Study on Globalization of Counterfeit Drugs and its Countermeasures
Project/Area Number |
22406005
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 海外学術 |
Research Field |
Medical pharmacy
|
Research Institution | Kanazawa University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
TANIMOTO Tsuyoshi 同志社女子大学, 薬学部, 教授 (80142123)
TSUBOI Hirohito 金沢大学, 薬学系, 准教授 (20319338)
YOSHIDA Naoko 金沢大学, 薬学系, 助教 (20565428)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥18,200,000 (Direct Cost: ¥14,000,000、Indirect Cost: ¥4,200,000)
Fiscal Year 2012: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2011: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2010: ¥6,760,000 (Direct Cost: ¥5,200,000、Indirect Cost: ¥1,560,000)
|
Keywords | カウンターフィットドラッグ / 偽造薬 / グローバル化 / 発展途上国 / 先進国 / バイアグラ / 真正性 / 低品質 / 生活習慣病治療薬 / 偽造医薬品 / 品質不良品 / 含量不足 / カウンターフィット薬 / ブロックバスター |
Research Abstract |
The status of counterfeit medicines in a developing country (Cambodia) was examined and compared with the global situation. It is concluded that target medicines of counterfeiters are similar in developing countries and the developed world, but medicines most widely used in the local area are more likely to be counterfeited, irrespective of their global importance. Substandard medicines are a huge problem in the pharmaceutical market in developing countries and improvements of quality control at manufacturing sites and distribution channels are urgently necessary.
|
Report
(4 results)
Research Products
(41 results)